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Stlmltrlsry 
The meningococcal class 1 outer membrane protein (OMP) plays an important role in the 
development of protective immunity against meningococcal infection, and is therefore considered 
to be a promising candidate antigen (Ag) for a meningococcal vaccine. The induction of an effective 
antibody response entirely depends upon T helper cells. To identify T cell epitopes of the OMP, 
we prepared 45 overlapping  synthetic peptides  representing the entire sequence of the class 1 
protein of reference strain H44/76.  Fully automated simultaneous  multiple peptide synthesis 
(SMPS) was used to assemble the 45 twenty met which overlapped by 12 amino acid residues 
on a 12/~mol scale. The peptides were tested for recognition by peripheral blood mononuclear 
cells (PBMC) obtained from 34 volunteers. Surprisingly, all synthetic peptides induced proliferative 
responses of PBMC isolated from one or more human histocompatibility leukocyte antigen (HLA)- 
typed immune adults.  With PBMC from seven nonimmune donors,  no proliferative response 
was observed. Immunodominant regions were found, recognized by PBMC from many volunteers, 
irrespective of their HLA type. Most of the immunodominant T cell epitopes are located outside 
the variable regions and, thus, will be conserved among different meningococcal (and gonococcal) 
strains. Furthermore, the overlapping peptides could be used to identify the epitopes recognized 
by OMP-specific T cell clones with known HLA restriction. It is interesting that the epitopes 
defined with the clones occur in highly conserved areas, shared by all neisserial porin proteins. 
In summary, this analysis of the T cell response to the meningococcal class 10MP constitutes 
a complete study of reactivity to a foreign protein, and illustrates  some important features of 
Ag recognition by T cells. Our data demonstrate unexpected diversity in the T cell recognition 
of the OMP, and imply that the T cell repertoire against foreign Ag may be greater than previously 
assumed. This observation is supported by recent data on the interaction of peptide and major 
histocompatibility complex (MHC) class II, the latter being much less selective than MHC class 
I.  Finally, a comparative  analysis pointed out the limitations of algorithms predicting T  cell 
determinants, and the importance of the empirical methodology provided by SMPS. 
A  vaccine against meningococci will aim at the induction 
of bactericidal and opsonic antibodies directed against 
capsular polysaccharides (CPS) 1, lipopolysaccharides (LPS) 
and outer membrane proteins (OMP) (1-3). In addition, LPS- 
neutralizing antibodies will contribute to the prevention of 
1 Abbreviations used in this  paper: CPS, capsular polysaccharides; FAB, fast 
atom bombardment;  OMP, outer membrane proteins; SMPS, simultaneous 
multiple  peptide  synthesis; SI, stimulation  index. 
septic shock. The effectiveness of these antibody responses 
depends on simultaneous activation of B and T cells by the 
vaccine (4, 5). Ig dass switch, affinity maturation, magni- 
tude of response, and induction of memory are regulated by 
T cells, although the molecular mechanisms involved in this 
regulation are largely unknown. The disadvantage of a lack 
ofT cell activation can dearly be observed with vaccines con- 
taining purified groups A and C CPS. For reasons that are 
yet unknown, saccharide antigens fail to induce functional 
T cell help. As a consequence of this, the immunogenicity 
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short duration (6, 7). This problem can be circumvented by 
conjugation of the saccharide epitopes to protein carrier mol- 
ecules  that provide the T  cell epitopes (8-10). 
In contrast to groups A and C CPS, the group B CPS is 
not immunogenic in humans (11). Alternative vaccine candi- 
dates are some OMP and LPS. Class  10MP  especially in- 
duce antibodies that are very potent in a bactericidal assay 
and in an infant rat challenge model (3). The amino acid se- 
quences of the protective B cell epitopes in the class 1 protein 
have been identified (12, 13). This sequence  information is 
now being used to prepare synthetic peptides containing these 
epitopes. Furthermore, isolated or chemically synthesized core 
oligosaccharides of LPS can be used as protective B cell epi- 
topes (14, 15). 
Like the meningococcal groups A and C  CPS,  synthetic 
OMP B cell epitopes and protective saccharide  epitopes of 
LPS have to be presented to the immune system in associa- 
tion with T cell epitopes to achieve an optimal response. Apart 
from the established  concept of conjugating B cell epitopes 
with carrier proteins like tetanus or diphtheria toxoid, the 
use of homologous, i.e., in this case meningococcal, T  cell 
epitopes has many advantages. Therefore, we have investigated 
recognition sites for human T cells in the meningococcal class 
10MP. 
In a previous paper (16) we described T  cell recognition 
of class 10MP-derived peptides containing possible T  epi- 
topes,  as predicted by the methods of Margalit et al.  (17), 
and Rothbard and Taylor (18). In this study, we screened the 
entire sequence of the OMP for occurrence of T cell epitopes. 
For this purpose, a series of 45 peptides (20 mer with 12 over- 
lapping amino acid residues;  see Fig.  1) was assembled  on 
micromolar scale using fully automated simultaneous mul- 
tiple peptide synthesis (SMPS). The peptides were tested for 
recognition by PBMC obtained from HLA-typed volunteers. 
To investigate OMP T  cell epitopes in detail and to define 
MHC restriction elements involved in T  cell recognition, 
OMP-specific T cell clones were isolated from immune adults. 
The epitopes recognized by the clones could be identified using 
the overlapping peptides. 
Materials and Methods 
Volunteers.  A group of 30 healthy adults with negative  anamnesis 
for meningococcal disease participated in this study. PBMC ob- 
tained from 27 individuals demonstrated a positive proliferative  re- 
sponse to the isolated class 10MP (i.e., stimulation index (SI) >3, 
see below). Sera from these volunteers contained high antibody 
titers to the class 10MP (data not shown). PBMC from three 
adults and from the umbilical cord blood of four neonates, demon- 
strated no T cell response to the class I OMP. Sera from these non- 
responders contained no anti-class 10MP antibodies. HLA typing 
of the volunteers was performed by standard National Institutes 
of Health  lymphocytotoxicity  test  for  HLA-ABC and by the 
propidium iodide method for HLA-DR and -DQ (19), using well 
defined sets of atloantisera and mAbs. 
Outer Membrane Protein.  The class 10MP was isolated from 
meningococcal reference strain H44/76 (B:lS:P1.7,16, originally 
obtained from Dr. E. Hohen, Akershus Central Hospital, Nord- 
byhagen, Norway), as described earlier (20). Because it is very 
difficult to separate the class I protein from the class 2/3 protein, 
a mutant strain was used which lacks the class 2/30MP (strain 
HIII-5) (21). 
Synthetic Peptides.  Fig. 1 shows the amino acid sequence of the 
overlapping peptides 1-45. Peptides with uncharged termini, i.e., 
N-acetylpeptide amides, containing 20 amino acid residues (with 
the exception of peptide 45 which is a 21 mer) were prepared. The 
native Met-144 residue was replaced by isosteric Nle (X) in pep- 
tides 17 and 18. All sequences were assembled  simultaneously  using 
an automated multiple peptide synthesizer, equipped with a 48- 
column reaction block (AMS 422; ABIMED Analysen-Technik 
GmbH, Langenfeld,  Germany), and N~-fluorenylmethoxycarbonyl 
(Fmoc)-protected  (22, 23) amino acids (Novabiochem,  IAufelfingen, 
Switzerland). The following  side-chain  protecting groups were used: 
tBu, tert-butyl ether (Ser, Thr, Tyr) or ester (Asp, Glu); Boc, tert- 
butyloxycarbonyl  (Lys);  Trt, triphenylmethyl (Asn, Gin, His), and 
Pmc, 2,2,5,7,8-pentamethylchroman-6-sulfonyl (Arg). The syn- 
theses were performed on a 12 #mol scale. Thus, each column was 
charged with 33  mg of 4-(2',4'-dimethoxyphenyl-Fmoc-amino- 
methyl)-phenoxy resin (polystyrene,  cross-linked  with 1% divinyl- 
benzene, 11~--200 mesh, functionalized  to the extent of  0.37 mmol/g 
resin; Novabiochem). Cleavage of Fmoogroups was effected  with 
piperidine/N,N-dimethylacetamide  (DMA), 2:8 (vol/vol), 2  x  5 
min (basic reaction time in cycles 1-5, thereafter gradually  increased 
to 12.5 rain, an automated option of the AMS 422). Stock-solutions 
(0.67 M) of Fmoc-amino  acids were prepared in high quality DMA, 
with three exceptions. Fmoc-Phe-OH and Fmoc-His(Trt)-OH were 
dissolved in N-methylpyrrolidone  (NMP) and Fmoc-Arg(Pmc)-OH 
in DMA/NMP, 1:1 (vol/vol). A 0.77 M stock solution of the ac- 
tivating  reagent  1-benzotriazolyloxy-tris-[N-pyrrolidino]-phos- 
phonium  hexafluorophosphate (PyBop) was prepared in DMA/ 
NMP, 4:1  (vol/vol), and a 4.0 M stock solution of N-methyl- 
morpholine (NMM) in DMA. In coupling steps, solutions  of  Fmoc- 
amino acid (75/~1, 50/zmol), PyBOP (65/zl, 50/~mol), and NMM 
(25/~1, 100 #mol), and an extra quantity (5/~1) of  DMA were added 
to each column. The coupling time was 30 min in cycles 1-6, and 
was gradually  increased to 60 min in further steps. Double couplings 
were performed in each cycle  of the syntheses. Each Fmoc cleavage 
or double coupling was separated  by six washings with DMA. The 
final Fmoc cleavage and DMA washings were followed  by manual 
addition of 0.5 ml acetic anhydride/triethylamine/DMA,  5:1:44 
(vol/vol/vol) to the columns. After 10 rain, the resin-bound pro- 
tected peptides were washed with DMA (3  x  0.5 ml), 2-methyl- 
2-butanol (2 x 0.5 ml), 2-methyl-2-butanol/acetic  acid, 9:1 (vol/vol) 
(2  x 0.5 ml), 2-methyl-2-butanol (3  x 0.5 ml), and diethyl ether 
(3  x  3 ml), successively,  and dried in vacuo. Side-chain  deprotec- 
tion of the peptides and cleavage from the resin was performed 
as proposed in reference 23. Peptides containing Arg (but not Trp) 
were deprotected with trifluoroacetic acid (TFA)/phenol,  95:5 
(vol/vol); peptides containing Trp (but not Arg) with TFA/ani- 
sole/1,2-ethanedithiol  (EDT), 95:2.5:2.5 (vol/vol/vol);  peptides  con- 
taining  Arg  and Trp  with TFA/phenol/anisole/EDT,  94:2:2:2 
(vol/vol/vol), and the remaining peptides with TFA/water, 95:5 
(vol/vol). The appropriate TFAAcavenger mixture was added to 
the columns, containing the resin-bound  protected peptides, at t =0, 
15, 30, 45, and 60 min (200/~1 each time). The combined filtrates 
(from individual columns) were left at room temperature for an 
additional hour. Next, diethyl ether (10 ml) was added, and the 
suspensions obtained were cooled to -20~  The peptide precipi- 
tates were collected by centrifugation (-20~  10 rain, 6240 g), 
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in  1 ml of acetic  acid/water,  9:1 (vol/vol), and lyophilized. 
The purity of the 45 peptides,  as determined by analytical  re- 
verse phase HPLC (Ca-column; water/acetonitrile/trifluoroacetic 
acid, gradient from 99:1:0.1 to 30:70:0.1),  varied between 50 and 
90%. Small aliquots ofpeptides 9, 18, 27, 36, and 45 were purified 
by semi-preparative  HPLC and subjected to fast atom bombard- 
ment (FAB) mass spectrometry. FAB mass spectra were recorded 
in the positive ion mode on a JEOL HX 110/HX 110 mass spec- 
trometer, equipped with a standard FAB source (JEOL, Tokyo, 
Japan) operated at 3 kV. Spectra were obtained using a magnet scan 
rate of 35 s from m/z 1800 to 2600.  The peptides were deposited 
on acid-etched stainless-steel  probe tips  with glycerol as matrix. 
In all cases, the protonated molecular ion (MH +) was detected at 
the expected value of m/z (monoisotopic values found/calculated: 
9, 2141.5/2141.1; 18, 2448.2/2448.2;  27, 2183.0/2183.1; 36, 2159.0/ 
2159.1; 45, 2302.1/2302.2). 
The crude peptides were used in immunological experiments. 
To obtain stock solutions, the peptides were dissolved in 1 ml of 
6 M urea/tris(hydroxymethyl) aminomethane, pH 7.0, and diluted 
with cuhure media (see below) to a concentration of 0.44 mM. 
In the immunological experiments, a final peptide concentration 
of 5 #M was used. 
ProlifemtionAssays.  To investigate the presence of  peptide-specific 
T cells in the peripheral blood, freshly isolated  PBMC (10S/well) 
were cultured in the absence or presence of antigen (6 #M) in 96- 
well roundbottomed microcuhure plates (150 #l/well). After 5 d, 
the cultures were pulsed with 0.5/zCi of [3H]thymidine. 16-18 h 
later,  all 96 wells  were harvested simultaneously with a 96-well 
sample harvester (Pharmacia/LKB, Turku, Finland).  The complete 
filters containing 96 spots were placed in plastic bags. Scintillation 
liquid (Pharmacia/LKB) was added, and the bags were sealed. Ra- 
dioactivity incorporated into DNA was determined with a Phar- 
macia/LKB 1205 Betaplate counter. The results obtained with six 
replicate cultures are expressed as the stimulation index (SI) which 
was calculated as the ratio of cpm obtained in the presence of Ag 
to the cpm obtained in the absence of Ag (media alone). 
Establishment oft Cell Clones.  PBMC were isolated by Ficoll- 
Isopaque (Pharmacia Fine Chemicals AB, Uppsala, Sweden) gra- 
dient centrifugation. Cells were cultured in RPMI  1640 (Gibco 
Laboratories, Paisley, Scotland) supplemented with t-glutamine (2 
mM), •-ME  (10 -s M), benzylpenicillin (100 IU/ml), streptomycin 
(100/xg/ml) and 10% heat-inactivated, pooled human AB serum. 
PBMC (10Vwell) were restimulated  in vitro with antigen (10 #M) 
in 96-well roundbottomed microcuhure plates (150/A/well). After 
7 d, T cell blasts were cloned by limiting dilution (0.5 cells/weU) 
in the presence of irradiated (25 Gy) autologous feeder cells (5  x 
104 PBMC/well) that had been pulsed with antigen (10 #M) for 
2 h. The cells were cultured in 96-well roundbottomed microcul- 
ture plates in the presence of recombinant IL-2 (Boehringer Mann- 
helm, Mannheim,  Germany) (12 U/ml) in a volume of 150/zl. 
Growing cultures were expanded by restimulation with Ag-pulsed 
irradiated feeder cells (5  x  l& PBMC/well) every 2 wk and ad- 
dition of human rll_,2 (2 U/well) weekly. To investigate the prolifer- 
ative response of the clones,  APC  (5  x  10  ~ PBMC/well) were 
preincubated with antigen (6/zM) or media (controls) in triplicate 
in 96-well roundbottomed microcuhure plates  for 2 h. After ir- 
radiation (25 Gy) of the APC,  1-2  x  104 washed T  cells were 
added to the wells. The cells were cultured in a volume of 150/A/well 
for  3  d.  16-18  h  before  harvest,  cultures  were  pulsed  with 
[ZH]thymidine.  Radioactivity incorporated into DNA was deter- 
mined as indicated previously. 
Results 
Screening of the PI. 7,16 Protein  for Occurrence of T Cell Epi- 
topes Using Series of Overlapping Peptides Spanning the Entire 
Sequence.  To identify T cell epitopes occurring in the menin- 
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Figure 1.  Amino acid sequence of the Pl.7,16 class 10MP of Neisseria 
meni,gitidb,  strain H44/76.  Synthetic peptides and their code numbers 
are indicated. N-acetylpeptide  amides, 20 met with 12 overlapping amino 
acid residues, were prepared. Peptide 45 is a 21 mer. The native Met-144 
residue was replaced by isosteric Nle (X) in peptides  17 and 18. Based 
on the putative model of the OMP (D), eight surface loops are repre- 
sented. Protective antibodies have been mapped to loops 1, 4, and 5. Most 
of the trans-membrane regions (ttttt,  above the P1.7,16 sequence) occur 
as amphipathic B sheets ([33~3[3).  T cell sites predicted by the AMPHI 
algorithm (17) are underlined.  (*) T  cell motifs described by Rothbard 
and Taylor (18). 
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Figure 2.  Proliferative response of PBMC isolated from an immune in- 
dividual (donor 15) to 45 overlapping peptides spanning the entire sequence 
of the class 10MP. The peptides which consisted of 20 amino acid residues 
and overlapped by t2 residues are numbered according to Fig. 1. Prolifera- 
tion was measured after 5 d of culture as indicated in Materials and Methods. 
Results of six replicate cultures are represented as the stimulation index 
(SI) which was calculated as (experimental cpm +  Ag)/(control cpm - 
Ag).  The background  was used  as the cutoff level  twice (background 
proliferation: 379  +_  14 cpm). The response to the purified P1.7,16 pro- 
tein is indicated  as OMP. 
gococcal class  10MP,  a series  of 45 peptides consisting of 
20 mer with an overlap of 12 amino acid residues (Fig.  1) 
was tested for T cell recognition.  Results of a representative 
experiment  performed  with  PBMC  from  an  immune  in- 
dividual are shown in Fig. 2. The positive responses to pep- 
tides  1,  28,  33,  35,  37-39  and 43-45  indicate recognition 
of at least six different T cell epitopes by this donor. Results 
obtained with PBMC from 27 immune, HLA-typed adults 
are represented in Fig. 3. A proliferative response to the purified 
class  10MP  was observed with PBMC from these volun- 
teers (Fig. 3, far right). Sera from these donors displayed an- 
tibody titers to meningococcal antigens. A positive response 
was recorded to one or more peptides with PBMC from each 
immune donor. All peptides were recognized. Because of the 
large number of positive responses it is impossible  to dis- 
cover association of T  cell recognition of a distinct peptide 
with the occurrence of a particular HLA haplotype. In three 
volunteers, no T  or B cell response was seen to the class  1 
OMP. With PBMC obtained from these nonimmune donors, 
no response was observed to any of the peptides. Because it 
is very difficult to find adults who lack immunity to menin- 
gococci, results obtained with lymphocytes isolated from um- 
bilical cord blood from four neonates were included in this 
study  as  additional  negative  controls.  With  the  neonatal 
PBMC,  no proliferative response was observed to the class 
10MP  or any of the peptides  (results  not  shown). 
A stacked bar diagram of the positive responses that were 
observed to each of the peptides in the individual donors is 
shown in Fig. 4 A. Results obtained with a threshold of SI = 2 
and SI--3 were qualitatively the same.  It is interesting  that 
many positive responses were  recorded for peptides corre- 
sponding to the COOH-terminal  part of the OMP. 
Correlation of Predicted Structural Properties with T Cell Rec- 
ognition of Synthetic Peptides.  The class  10MP  is a cation- 
selective porin (21) which occurs in the outer membrane as 
HLA  phenotypes 
Donor  DR  OOw 
1  4,w10  5,8 
2  3  2 
3  3,7  2 
4  w15[2),w13[w6)  6 
5  w11(5),7  2,7 
6  w11[S],w10  5,7 
7  w13(w6)  6 
8  w15(2],4  S,8 
9  w15(2),7  6,9 
10  w15(2),w8  4,6 
11  w12(5),w13(w6)  6,7 
12  wt1(5)  ? 
13  3.7  2 
14  3,4  2,8 
15  3,w12(5)  2,7 
16  w15[2),7  6,9 
17  1,3  2,5 
I8  3,4  2,s 
19  1.7  5,9 
20  4,w8  q,8 
21  l,w13(w6)  5,6 
22  w  16(2),w11[5)  5,? 
23  w11[5),w13[w6)  6,7 
24  1,3  2,5 
25  1,w13(w6)  5,6 
26  W13(w6)  5 
27  w13(W6)  5 
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Figure 3.  Schematic diagram of proliferative responses obtained with PBMC from HLA-typed immune adults to 45 overlapping peptides spanning 
the meningococcal class 10MP. The sequence of the 20 mer which overlapped by 12 residues is represented in Fig. 1. The HLA-DR and -DQ phenotypes 
of the donors are shown. Proliferative responses were measured after 6 d of culture as indicated in Materials and Methods.  SI were calculated as (ex- 
perimental  cpm  +  Ag)/(control  cpm  -  Ag).  (Open  boxes) SI <2; (light stippled boxes) SI=2-3;  (dark stippled boxes) SI=3-5;  (solid boxes) SI >5. 
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Figure 4.  (,4) Histogram representing the T cell responses to each of 
the 45 overlapping peptides spanning the meningococcal class 10MP. 
For each peptide, the stacked bar is a cumulation of SI (only SI >-3) as 
obtained with PBMC from 27 immune volunteers. Individual responses 
are shown in Fig. 3.  (B) Prediction  of amphipathic  cx helices from the 
primary sequence of the H44/76 class t  OMP using the computer pro- 
gram AM.PHI (block length =  11; threshold = 4) (17). The amphipathicity 
score of each segment is shown. (Black boxes, top) Presence of T cell epi- 
tope motifs according to Kothbard and Taylor (18). (C) Tetrapeptide fre- 
quency profile of the H44/76 class 10MP. For each position along the 
sequence, the frequency of the local tetrapeptide is noted. The frequency 
was computed from the number of occurrences of this amino acid pattern 
within all known human somatic protein sequences (NBRF-PIR data- 
base). Regions corresponding  to quadruples which do not occur in the 
human somatic reference set indicate putative  T cell epitopes. 
a trimer.  7~ans-membrane regions presumably occur as am- 
phipathic 3 sheets. The protective B cell epitopes were found 
to be located on top of surface loops 1, 4,  and 5 (12,  13). 
Amphipathic/~ sheets and surface loops are indicated in the 
primary sequence of the OMP (Fig.  1) to facilitate associa- 
tion  with  the  overlapping peptides.  Segments with  high 
propensity to form amphipathic c~ helices, proposed to be 
related to T cell epitope formation, were predicted with the 
computer program AMPHI (17).  Results of this analysis are 
shown in Fig. 4 B. Sequences containing predicted amphipathic 
o~ helices are underlined in the primary sequence of the P1.7, 
16 protein (Fig.  1). The T  cell epitope motif described by 
Rothbard and Taylor (18)  (charged residue or glycine, fol- 
lowed by two or three hydrophobic residues and then polar 
residues or glycine) occurred 14 times in the OMP.  These 
sequences are indicated with asterisks in Fig. 1. Amphipathic 
c~ helices do not always coincide with the Rothbard motif. 
Finally, the degree of the OMP homologies with human 
somatic self sequences was evaluated. Previous investigations 
have suggested a coincidence between the occurrence of T 
cell epitopes and "rare" sequence patterns not found in the 
host somatic self proteins (25). The OMP sequence was ana- 
lyzed as a series of single residue overlapping tetrapeptides 
and compared to a reference set of human somatic self pro- 
tein sequences available  in the NBRF-PIR database (release 
29.0, June 1991). The catalog of tetrapeptide frequencies was 
calculated over this set of reference. The OMP sequence was 
represented by corresponding tetrapeptide frequencies (noted 
at positions 1, 2 etc. of the sequence). The graphical represen- 
tation of the results (Fig. 4 C) allows the immediate location 
of putative T cell epitopes (i.e., regions of quadruples absent 
from the human somatic self reference set). 
To evaluate the predictive value of the algorithms described 
by Margalit  et al.  (17),  and by Rothbard  and Taylor (18), 
the results were cross-classified into four groups: (a) T  cell 
epitope was predicted; peptide was recognized; (b) T cell epi- 
tope was predicted; peptide was not recognized; (c) T  cell 
epitope was not predicted; peptide was recognized; and (d) 
T cell epitope was not predicted; peptide was not recognized. 
The results were analyzed using a normal distribution that 
was found to be a fair approximation of the binomial distri- 
bution. Neither algorithm demonstrated a positive correla- 
tion  with  T  cell  recognition  (tested  at  a  99%  level  of 
significance, To ~0.1). It is interesting that some association 
was found to exist between T cell recognition of a given pep- 
tide and occurrence of surface loops in the corresponding re- 
gion of the OMP (tested at a 99% level of significance, To 
=  4.1).  ~ans-membrane regions or/~ sheets did not occur 
more frequently in peptides that were found to contain T 
cell epitopes (To ~<1.9). The prediction of "nonself" regions 
by comparing the class  10MP  sequence with a catalog of 
all known human somatic self proteins was found to be in- 
dicative for some epitopes, but failed to predict others. 
Recognition of Overlapping Synthetic Peptides by OMP-specific 
T Cell Clones.  T  call clones were established from healthy 
adults with high antibody titers to the class 10MP. PBMC 
from these volunteers demonstrated a strong proliferative re- 
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cell dones isolated were found to be of the helper phenotype. 
Analysis of surface molecules by flow cytometry revealed ex- 
pression of CD3, CD4 and the TCR-odB (results not shown). 
Clones AZ5.4 and AZ14.0 which had been selected with the 
peptide OMP(49-61) were found to recognize the overlap- 
ping peptides 6 and 7 (Table 1). Blocking experiments with 
mAbs against MHC class I/II molecules, as well as the use 
of a panel of HLA-typed APC, revealed HLA-DRw15(2) re- 
striction of the AZ clones (16, and Wiertz et al., manuscript 
in preparation). The T cell doneJP5.3 was isolated from the 
peripheral blood of donor 6 using the P1.7,16 class 10MP. 
Out of the 45 overlapping peptides tested for recognition 
by this clone, peptide 13 induced a strong proliferative  re- 
sponse. In addition, some proliferation was observed to pep- 
tide 12. Ag recognition by done JP5.3 was HLA-DR10 re- 
stricted. The JV1 T cells that were isolated from donor 15 
responded to peptides 38 and 39.  In this case, recognition 
was found to be associated  with HLA-DRw11(5). Clone  JS17.4 
responded to peptide 38 as well. However,  this clone was 
HLA-DR1 restricted (16). Clone JS21.6 demonstrated a posi- 
tive response to only one single peptide, i.e., peptide 45. In 
this case, antigen recognition occurred in the context of HLA- 
DR1 exclusively. 
Discussion 
T cell recognition of a peptide antigen requires stabiliza- 
tion of the oligopeptide in the Ag binding groove of a MHC 
molecule. The TCR interacts (presumably via its CDIk 3 re- 
gion) with certain TCIk-exposed side chains of the Ag. At 
the same time, the TCIk binds to the ct helices of the MHC 
molecule (presumably via the CDIk 1 and 2 regions) (26). 
A peptide that contains the appropriate side chains to interact 
with the Ag-binding pocket(s) of a particular MHC mole- 
cule, will adopt its final conformation in the trimolecular 
complex with MHC and TCR. As a consequence of this, 
chemically assembled peptides lacking a prerequisite confor- 
mation can be used to study the trimolecular interaction of 
TCIk, Ag, and MHC. This is in contrast with Ag recogni- 
tion by Ig Fab regions which usually requires a defined sec- 
ondary and tertiary structure of the epitope. In case of MHC 
class II-restricted T cell recognition, processing of the pro- 
tein Ag by proteolytic enzymes usually precedes or coincides 
with the association  of antigenic determinants and MHC. 
T cell epitopes may therefore occur throughout a protein and 
are not limited to surface-exposed  regions. Consequently, frag- 
mentation of a protein Ag is required to enable systematic 
identification of T cell epitopes. In vitro cleavage with pro- 
teolytic enzymes, as well as the construction of overlapping 
fragments by recombinant DNA methods, have led to suc- 
cessful identification of T cell epitopes in many proteins. How- 
ever, a fruitful alternative is provided by SMPS which enables 
assembly of large numbers of overlapping peptides spanning 
the entire protein. 
SMPS using polyethylene rods as the solid support was 
introduced by Geysen et al.  (27).  In its original form the 
method has been used to detect the interaction of antibodies 
with synthetic peptides, which remain attached to the sup- 
port ("Pepscan"). However, in T cell proliferation assays, flee 
peptides are required. Recently, two procedures for cleaving 
the peptides from the rods were proposed (28-30). In both 
cases, small quantities (nanomolar range) of peptides with 
unnatural COOH-terminal modifications, i.e., an additional 
aspartyl residue (28), or an artificial diketopiperazine (29, 30), 
have been obtained. Diketopiperazine-extended  peptides have 
been used for T cell epitope mapping of hen egg-white lyso- 
zyme (31). A thorough investigation of an antigen like the 
meningococcal  class 10MP, using PBMC from a large panel 
of blood donors and numerous T  cell clones,  requires  the 
availability on micromolar scale of overlapping peptides span- 
ning the entire sequence. A method of SMPS which yields 
larger, i.e., micromolar, quantities of free peptides, has been 
developed  by Houghton (32). In this approach, conventional 
solid supports are compartmentalized in permeable polypro- 
pylene bags (the "tea bag" approach).  Finally, several mul- 
tiple column systems for peptide synthesis  on micromolar 
scale have been introduced. These systems can be operated 
manually (33)  or automatically (34-37).  Fully automated 
multiple-column  synthesis is very suitable to support immuno- 
logical research, and was used in the present study. A series 
of overlapping peptides spanning the entire sequence of the 
meningococcal OMP was prepared on 12/~mol scale. To min- 
imize the risk of missing determinants, 20 mer were chosen 
which overlapped  by 12 amino acid residues  (Fig.  1). 
Results of a representative proliferation experiment applying 
the synthesized overlapping 20 met are shown in Fig. 2. Four 
individual peptides and two sets of adjacent peptides were 
capable of recalling proliferation of PBMC obtained from an 
immune donor. Thus, at least six T cell determinant regions 
could be defined. The results of proliferation experiments with 
PBMC from 27 immune donors (Figs. 3 and 4 A) revealed 
strong diversity of the T cell repertoire involved in recogni- 
tion of the OMP. To a large extent, this will reflect the genetic 
polymorphism in the MHC of the population. In addition, 
the in vitro T cell response may be influenced by the relative 
frequency of OMP-specific precursors and the state of activa- 
tion in the host before the experiment. 
It is surprising that all 45 peptides were recognized by one 
or more volunteers. Thus, numerous T cell determinants must 
be present in one single protein. This finding can, at least 
in part, be explained by recent data on the interaction of pep- 
tide with MHC class II. In contrast to MHC class I, class 
II seems to bind peptides with low affinity in the processing 
compartment (fast-on/fast-off)  (38, 39). This may allow the 
capture of a large variety of peptides. Indeed, characteriza- 
tion of naturally processed peptides eluted from MHC class 
II revealed the presence of different determinants of a single 
protein.  In  addition,  several overlapping peptides corre- 
sponding to the same core determinant were identified (40). 
Even within a single T cell epitope, different ways of MHC 
binding may occur. For a peptide corresponding to amino 
acid residues 49-61 of the meningococcal class 10MP, puta- 
tive MHC (and TCR) contact residues were elucidated using 
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Antigen  Resides  Peptide sequence 
Recognition by 
T  cell  clones 
(SI) 
AZ5.4  AZ14.0 
Purified OMP  -  169  55 
Peptide 4  25-44  QAANGGASGQVKVTKVTKAK  <2  <2 
Peptide 5  33-52  GQVKVTKVTKAKSRIRTKIS  <2  <2 
Peptide 6  41-60  TKAKSRIRTKISDFGSFIGF  6  64 
Peptide 7  49-68  TKISDFGSFIGFKGSEDLGD  57  65 
Peptide 8  57-76  FIGFKGSEDLGDGLKAVWQL  <2  <2 
Jp5.3 
Purified OMP  -  103 
Peptide  11  81-100  SVAGGGATQWGNRESFIGLA  <2 
Peptide  12  89-108  QWGNRESFIGLAGEFGTLRA  4 
Peptide  13  97-116  IGLAGEFGTLRAGRVANQFD  63 
Peptide  14  105-124  TLRAGRVANQFDDASQAIDP  <2 
Peptide  15  113-132  NQFDDASQAIDPWDSNNDVA  <2 
JV1 
Purified OMP  -  19 
Peptide 36  281-300  GDKTKNSTTEIAATASYRFG  <2 
Peptide 37  289-308  TEIAATASYRFGNAVPRISY  <2 
Peptide 38  297-316  YRFGNAVPRISYAHGFDFIE  39 
Peptide 39  305-324  RISYAHGFDFIERGKKGENT  31 
Peptide 40  313-332  DFIERGKKGENTSYDQIIAG  <2 
JS17.4 
Purified OMP  -  7 
Peptide 36  281-300  GDKTKNSTTEIAATASYRFG  <2 
Peptide 37  289-308  TEIAATASYRFGNAVPRISY  <2 
Peptide 38  297-316  YRFGNAVPRISYAHGFDFIE  13 
Peptide 39  305-324  RISYAHGFDFIERGKKGENT  5 
Peptide 40  313-332  DFIERGKKGENTSYDQIIAG  <2 
JS21.6 
Purified OMP  -  94 
Peptide 42  329-348  IIAGVDYDFSKRTSAIVSGA  <2 
Peptide 43  337-356  FSKRTSAIVSGAWLKRNTGI  <2 
Peptide 44  345-364  VSGAWLKRNTGIGNYTQINA  2 
Peptide 45  353-372  NTGIGNYTQINAASVGLRHK  68 
APC were pulsed with Ag (6/~M peptide or 0.08/~M  OMP) in 96-weU microculture plates for 2 h. After irradiation, T cells were added to the 
wells. 3 d later,  proliferation was measured as indicated in Materials and Methods. Results of triplicate cultures are expressed as Sl calculated as 
(experimental cpm  +  Ag)/(control cpm  -  Ag). 
a number of HLA-DR2-restricted OMP(49~x)-specific T  cell 
clones.  Different  modes of interaction  with DR2  (and the 
clonotypic  T  cell receptors)  were observed  (Wiertz  et al., 
manuscript in preparation). This also suggests that peptide- 
MHC  class II binding  is less  stringent. 
In the meningococcal class 1 protein,  immunodominant 
regions  were found,  recognized by PBMC  of most  volun- 
teers,  irrespective of their HLA type.  This observation can 
be explained in several ways. The 20 mer could accommo- 
date  several overlapping T  cell epitopes,  recognized  in  the 
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one  or  more  of the  peptides  may contain  a  single  im- 
munodominant T cell epitope that can interact with several 
or all MHC class II haplotypes (42-44). To define the MHC 
molecule(s) involved in presentation of a particular region 
of the meningococcal class 10MP,  T  cell clones were iso- 
lated from immune donors. The epitopes recognized by the 
T cell clones could be identified with the overlapping 20 met 
(Table 1). The HLA restriction elements involved in presen- 
tation to the clones were elucidated using a panel of APC 
with  known  HLA  specificity  (i.e,  PBMC,  homozygous 
EBV-BC, L cell transfectants) (16, and Wiertz et al., manu- 
script in preparation). 
Most of the immunodominant T cell determinants are lo- 
cated outside the variable regions which are limited to the 
protective surface loops 1, 3, and 5 (13). Consequently, these 
T  cell epitopes will be conserved among different menin- 
gococcal (and gonococcal) strains (13,  45),  indicating that 
they are common T helper antigenic sites. All epitopes defined 
with the (limited number of) T cell clones correspond to puta- 
tive trans-membrane regions of the OMP. These regions, in 
particular,  are highly conserved in all neisserial  porins,  in- 
cluding  the  meningococcal class  1  and  20MP  and  the 
gonococcal PIA and PIB proteins (13, 45). The T  cell epi- 
topes identified, in combination with different B cell neu- 
tralizing determinants, may be useful in the development of 
a synthetic or recombinant multivalent meningococcal (and 
gonococcal) vaccine. 
A number of algorithms designed to predict T cell deter- 
minants were applied to the meningococcal class 10MP. The 
results were compared with the data obtained with the over- 
lapping peptides in proliferation assays. Segments with high 
propensity to form amphipathic ot helices,  amphipathic 
sheets, putative nonself regions and T cell epitope motifs ac- 
cording to Rothbard and Taylor (18) defined some determinant 
regions, but missed others. There is some correlation between 
T  cell recognition and the presence of surface loops in the 
corresponding region of the OMP. This observation may be 
explained in several ways.  In vivo binding of antibodies to 
the OMP is limited to surface loops. At the site of infection, 
antigen-specific B cells, that have been found to be very effident 
antigen-presenting cells (46, 47), may selectively capture OMP 
surface loops from debris that contains (partially) degraded 
meningococci. In addition, surface loops may be more easily 
accessible to proteolytic enzymes during processing and may 
associate  with MHC  molecules more frequently. 
Cleavage sites for proteolytic enzymes involved in antigen 
processing may be used as a predictive tool for the identification 
of potential MHC-binding sequences,  and, thus, potential 
T cell epitopes (24).  In the primary sequence of the menin- 
gococcal class 10MP, preferential cleavage sites for cathepsin 
D  were found to precede several immunodominant T  cell 
epitopes. Especially at the COOH terminus, a high frequency 
of putative cleavage sites for cathepsin D coincided with the 
presence of immunodominant regions. 
In conclusion, prediction of MHC class II-restricted T cell 
epitopes is still intricate. Recently, some data have become 
available on primary sequence motifs present in MHC class 
I and II-bound peptides (40, 48-50).  Analysis of the con- 
tents of MHC class I grooves revealed a number of anchoring 
residues at certain positions of the peptide antigens (48-50). 
Crystallographical data on peptide-loaded HLA-B27 mole- 
cules indicated the presence of nonamers bound in an extended 
conformation in the antigen-binding groove (51). In contrast, 
peptides eluted from MHC class II molecules showed no po- 
sitions with conserved residues, whereas the length of the 
peptides eluted was found to vary from 13 to 17 amino acid 
residues (40). Overlapping peptides corresponding to the same 
core determinant were identified, having identical NH2 ter- 
mini, but varying in length. Similar observations were made 
when the MHC and TCR contact residues were identified 
for a peptide corresponding to amino acid residues 49-61 of 
the meningococcal class 10MP  (Wiertz et al., manuscript 
in preparation). Until now, no consistent MHC class II an- 
choring residues,  particular conformation, size, or sequence 
motifs have been identified. In summary, the most reliable 
approach to identify MHC class II-restricted T  cell deter- 
minants within a protein will be a systematical screening using 
chemically synthesized overlapping peptides spanning the en- 
tire sequence. 
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